Clay B. Siegall

2009

In 2009, Clay B. Siegall earned a total compensation of $2.5M as President and CEO at Seattle Genetics, a 9% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$346,351
Option Awards$1,578,937
Salary$600,071
Other$7,890
Total$2,533,249

Siegall received $1.6M in option awards, accounting for 62% of the total pay in 2009.

Siegall also received $346.4K in non-equity incentive plan, $600.1K in salary and $7.9K in other compensation.

Rankings

In 2009, Clay B. Siegall's compensation ranked 1,859th out of 9,885 executives tracked by ExecPay. In other words, Siegall earned more than 81.2% of executives.

ClassificationRankingPercentile
All
1,859
out of 9,885
81st
Division
Manufacturing
651
out of 3,690
82nd
Major group
Chemicals And Allied Products
120
out of 866
86th
Industry group
Drugs
76
out of 638
88th
Industry
Biological Products, Except Diagnostic Substances
10
out of 133
93rd
Source: SEC filing on April 13, 2012.

Siegall's colleagues

We found four more compensation records of executives who worked with Clay B. Siegall at Seattle Genetics in 2009.

2009

Thomas Reynolds

Seattle Genetics

Chief Medical Officer

2009

Eric Dobmeier

Seattle Genetics

Chief Operating Officer

2009

Morris Rosenberg

Seattle Genetics

EVP, Process Sciences

2009

Todd Simpson

Seattle Genetics

Chief Financial Officer

News

In-depth

You may also like